Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1502

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 6
Chunk 1502
---
,705)
  
    Gain
    (Loss) on extinguishment of debt 
     857,723  
     (887,946)
  
    Other income 
     90,000  
     44,500 
  
    Total
    other income (expenses), net 
     651,657  
     (912,918)

    Net
    loss 
    $(2,439,625) 
    $(4,783,689)

    Net
    loss per common share: 

    Basic 
    $(0.08) 
    $(0.18)
  
    Diluted 
    $(0.08) 
    $(0.18)

    Weighted
    average number of common stock outstanding: 

    Basic 
     28,783,045  
     26,405,109 
  
    Diluted 
     28,783,045  
     26,405,109 

The
accompanying notes are an integral part of these financial statements

F-4

JUPITER
NEUROSCIENCES, INC.

STATEMENTS
OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

    Shares  
    Amount  
    in
    Capital  
    Deficit  
    Deficit 

    Common
    Stock  
    Additional
    Paid  
    Accumulated  
    Total Stockholders’
                                                                                Equity 

    Shares  
    Amount  
    in
    Capital  
    Deficit  
     (Deficit) 
  
    December
    31, 2023 
     26,526,405  
    $2,652  
    $17,778,498  
    $(23,582,504) 
    $(5,801,354)
  
    Stock-based
    compensation 
     -  
     -  
     1,840,908  
     -  
     1,840,908 
  
    Issuance
    of restricted stock units for forgiveness of accrued salary 
     -  
     -  
     10,000  
     -  
     10,000 
  
    Issuance
    of stock options for forgiveness of accrued salary 
     -  
     -  
     50,000  
     -  
     50,